tirzepatide senior discount Medicare is expanding access to weight-loss GLP-1 medications. Starting July 1, eligible Medicare beneficiaries can receive GLP-1 prescriptions for obesity for $50 a month through a new federal pilot program, even without Millions of older Americans are

Ozempic is not appropriate for those with insulin-dependent diabetes

Researchers have reported that NA-931 can enhance insulin secretion, regulate appetite, and support metabolic balance all in a single, well-characterized peptide

My glucose levels dropped from high to normal as well

However, dietitians have shown concern over the long-term consequences of taking the drug

Who Should Consider Alternatives Anyone with personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 should avoid all GLP-1 and related medications including Retatrutide

Discuss this information with your own physician or healthcare provider to determine what is right for you